Brief Association Letters
aDepartment of Psychiatry, Taiwan Adventist Hospital
bDepartment of Psychiatry, Mackay Memorial Hospital
cMackay Medicine, Nursing and Management College
dDepartment of Psychiatry, Taipei Veterans General Hospital
eDivision of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan
*Cheng-Dien Hsu and Ruu-Fen Tzang contributed equally to the writing of this article.
Correspondence to Shih-Jen Tsai, MD, Department of Psychiatry, Taipei Veterans General Hospital, No. 201 Shih-Pai Road, Sec. 2, Taipei, Taiwan 11217, ROC Tel: +886 2 2875 7027; fax: +886 2 2872 5643; e-mail: email@example.com
Received February 9, 2012
Accepted May 27, 2012
Attention deficit hyperactivity disorder (ADHD) is a complex genetic disorder that is caused by multiple heritable and environmental factors. Serotonergic system-related genes are likely to be involved in the mechanisms underlying ADHD, because serotonin dysregulation has been related to impulsive and aggressive behavior in children, and has thus been hypothesized to play a causal role in ADHD. The firing rate of the dorsal raphe serotonergic neurons is modulated by somatodendritic 5-hydroxytryptamine 1A (5-HT1A) autoreceptors. The human 5-HT1A receptor gene (HTR1A) transcription is modulated by a functional C-1019G promoter polymorphism (rs6295). In a case–control association study with 78 Korean ADHD patients and 107 normal controls, Shim et al. (2010) found a significant difference in the genotype distributions and allele frequencies of HTR1A C-1019G between the ADHD group and the control group (P=0.044 and 0.017, respectively). Tryptophan hydroxylase 2 (TPH2) is a rate-limiting enzyme in the biosynthesis of serotonin and is expressed exclusively in the brain. In 103 German families with 225 ADHD children, Walitza et al. (2005) reported a preferential transmission for two polymorphisms in TPH2’s regulatory region (rs4570625, P=0.049; rs11178997, P=0.034).
In the present study, we sought to replicate these findings in a Taiwanese sample by carrying out a family-based association study. Our sample included 282 Taiwanese families who had at least one child diagnosed with ADHD, and the sample has been reported in our previous study (Hsu et al., 2012). Each patient was diagnosed with ADHD according to the DSM-IV criteria by a senior board-certified child psychiatrist. Patients were excluded if there was any evidence of conduct disorder, mood disorder, anxiety disorder, Tourette’s syndrome, mental retardation (IQ<70), pervasive developmental disorder, or neurological conditions. The study was approved by the Ethics Committee of the Taiwan Adventist Hospital. Written informed consent was obtained from all participants. We genotyped these three polymorphisms (rs6295, rs4570625, and rs11178997) using high-throughput MALDI-TOF mass spectrometry (Sequenom Inc., San Diego, California, USA). Transmission disequilibrium test analyses for the three polymorphisms in the ADHD trios were carried out using PLINK (http://pngu.mgh.harvard.edu/∼purcell/plink/index.shtml).
Of the total 312 probands in 282 families, 257 (82.4%) were boys and 55 (17.6%) were girls. Their ages ranged from 6 to 24 years, with a mean age of 13.0±2.9 (SD) years. The genotype frequencies of the three polymorphism in the probands, fathers, and mothers were rs6295 (CC/CG/GG): 187/104/18, 163/95/21, and 163/101/20; rs4570625 (GG/GT/TT): 63/150/97, 61/142/76, and 61/148/73; and rs11178997 (TT/TA/AA): 217/86/8, 194/79/7, and 200/75/8. Analysis of the transmission disequilibrium test in the ADHD parent–proband trios showed no significant differences in the frequency between transmitted (T) and nontransmitted (NT) minor alleles for the three polymorphisms (rs6295-G: T/NT=94/188, P=0.099; rs4570629-G: T/NT=150/162, P=0.500; rs11178997-A: T/NT=80/84, P=0.755).
Our family-based study found no association between the HTR1A (rs6295), TPH2 (rs4570625 and rs11178997) polymorphisms and ADHD, and, therefore, does not support the earlier reports that described a significant association (Walitza et al., 2005; Shim et al., 2010).
Conflicts of interest
There are no conflicts of interest.
Hsu CD, Tzang RF, Loh EW, Liou YJ, Hong CJ, Tsai SJ. Family-based association study of cocaine- and amphetamine-regulated transcript (CARTPT) and protein interaction with C-kinase-1 (PICK1) genes in attention-deficit hyperactivity disorder. Psychiatry Res. 2012 [Epub ahead of print]
Shim SH, Hwangbo Y, Kwon YJ, Jeong HY, Lee BH, Hwang JA, et al. A case–control association study of serotonin 1A receptor gene and tryptophan hydroxylase 2 gene in attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:974–979
Walitza S, Renner TJ, Dempfle A, Konrad K, Ch Wewetzer, Halbach A, et al. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Mol Psychiatry. 2005;10:1126–1132